Volume 21, Number 2—February 2015
Research
Refining Historical Limits Method to Improve Disease Cluster Detection, New York City, New York, USA
Table 2
Diseases included in analyses using HLMrefined and details of customizations, New York City, New York, USA, May 20–August 5, 2013*
| Disease | Minimum no. cases in UHF neighborhood to qualify for signal | Further customization |
|---|---|---|
| Amebiasis | 5 | |
| Anaplasmosis (human granulocytic) | 3 | |
| Babesiosis | 3 | |
| Campylobacteriosis | 8 | |
| Cholera | 3 | |
| Cryptosporidiosis | 5 | |
| Cyclosporiasis | 3 | |
| Dengue | 3 | |
| Ehrlichiosis (human monocytic) | 3 | |
| Giardiasis | 5 | |
| Haemophilus influenzae disease, invasive | 3 | |
| Hemolytic uremic syndrome | 3 | |
| Hepatitis A | 5 | |
| Hepatitis B (acute) | 2† | |
| Hepatitis D | 2† | |
| Hepatitis E | 2† | |
| Legionellosis | 5 | |
| Listeriosis | 3 | |
| Malaria | 3 | |
| Meningitis, bacterial | 4 | |
| Meningitis, viral (aseptic) | 3 | |
| Meningococcal disease (Neisseria meningitidis) | 3 | |
| Paratyphoid fever | 3 | |
| Rickettisalpox | 3 | |
| Rocky Mountain spotted fever | 3 | Restrict analysis to confirmed, probable, and suspected cases and implement a 4-wk lag to allow for data accrual |
| Shiga toxin–producing Escherichia coli (including E. coli O157:H7) infection | 3 | |
| Shigellosis | 10 | |
| Staphylococcus aureus infection, vancomycin intermediate | 3 | |
| Streptococcus (group A) disease, invasive | 5 | Restrict analysis to confirmed, probable, suspected, and pending cases |
| Streptococcus (group B) disease, invasive | 5 | |
| Streptococcus pneumoniae disease, invasive | 5 | |
| Typhoid fever | 3 | |
| Vibrio spp. infection, noncholera (including parahaemolyticus and vulnificus) | 3 | |
| West Nile disease | 3 | |
| Yersiniosis | 3 |
* HLMrefined, refined method applied starting May 20, 2013; UHF, United Hospital Fund.
†These are the only diseases for which the signaling threshold was decreased below 3 cases.
1Current affiliation: RTI International, Research Triangle Park, North Carolina, USA.
2Current affiliation: Colorado Department of Public Health and Environment, Denver, Colorado, USA.
Page created: January 20, 2015
Page updated: January 20, 2015
Page reviewed: January 20, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.